![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2022
Anzahl der Publikationen: 2
2022
Wang, Katharina 
ORCID: https://orcid.org/0000-0002-7795-1395; Schütze, Ina; Gulde, Sebastian; Bechmann, Nicole ORCID: https://orcid.org/0000-0002-6932-333X; Richter, Susan ORCID: https://orcid.org/0000-0002-3549-2477; Helm, Jana; Lauseker, Michael; Maurer, Julian; Reul, Astrid; Spoettl, Gerald; Klink, Barbara; William, Doreen; Knösel, Thomas; Friemel, Juliane; Bihl, Michel ORCID: https://orcid.org/0000-0002-5884-739X; Weber, Achim; Fankhauser, Maria; Schober, Laura; Vetter, Diana; Broglie Däppen, Martina; Ziegler, Christian G ORCID: https://orcid.org/0000-0002-4345-696X; Ullrich, Martin ORCID: https://orcid.org/0000-0001-6104-6676; Pietzsch, Jens; Bornstein, Stefan R; Lottspeich, Christian; Kroiss, Matthias ORCID: https://orcid.org/0000-0002-7628-3161; Fassnacht, Martin; Wenter, Vera Ursula Julia ORCID: https://orcid.org/0000-0001-7385-5702; Ladurner, Roland; Hantel, Constanze; Reincke, Martin ORCID: https://orcid.org/0000-0002-9817-9875; Eisenhofer, Graeme; Grossman, Ashley B; Pacak, Karel ORCID: https://orcid.org/0000-0002-3541-3767; Beuschlein, Felix ORCID: https://orcid.org/0000-0001-7826-3984; Auernhammer, Christoph J; Pellegata, Natalia S und Nölting, Svenja ORCID: https://orcid.org/0000-0002-7064-590X
(2022):
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
In: Endocrine-Related Cancer, Bd. 29, Nr. 6: S. 285-306
ORCID: https://orcid.org/0000-0002-7795-1395; Schütze, Ina; Gulde, Sebastian; Bechmann, Nicole ORCID: https://orcid.org/0000-0002-6932-333X; Richter, Susan ORCID: https://orcid.org/0000-0002-3549-2477; Helm, Jana; Lauseker, Michael; Maurer, Julian; Reul, Astrid; Spoettl, Gerald; Klink, Barbara; William, Doreen; Knösel, Thomas; Friemel, Juliane; Bihl, Michel ORCID: https://orcid.org/0000-0002-5884-739X; Weber, Achim; Fankhauser, Maria; Schober, Laura; Vetter, Diana; Broglie Däppen, Martina; Ziegler, Christian G ORCID: https://orcid.org/0000-0002-4345-696X; Ullrich, Martin ORCID: https://orcid.org/0000-0001-6104-6676; Pietzsch, Jens; Bornstein, Stefan R; Lottspeich, Christian; Kroiss, Matthias ORCID: https://orcid.org/0000-0002-7628-3161; Fassnacht, Martin; Wenter, Vera Ursula Julia ORCID: https://orcid.org/0000-0001-7385-5702; Ladurner, Roland; Hantel, Constanze; Reincke, Martin ORCID: https://orcid.org/0000-0002-9817-9875; Eisenhofer, Graeme; Grossman, Ashley B; Pacak, Karel ORCID: https://orcid.org/0000-0002-3541-3767; Beuschlein, Felix ORCID: https://orcid.org/0000-0001-7826-3984; Auernhammer, Christoph J; Pellegata, Natalia S und Nölting, Svenja ORCID: https://orcid.org/0000-0002-7064-590X
(2022):
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.
In: Endocrine-Related Cancer, Bd. 29, Nr. 6: S. 285-306
Helm, Jana; Drukewitz, Stephan; Poser, Isabel; Richter, Susan; Friedemann, Markus; William, Doreen; Mohr, Hermine; Nolting, Svenja; Robledo, Mercedes; Bornstein, Stefan R.; Eisenhofer, Graeme und Bechmann, Nicole
(2022):
Treatment of Pheochromocytoma Cells with Recurrent Cycles of Hypoxia: A New Pseudohypoxic In Vitro Model.
In: Cells, Bd. 11, Nr. 3, 560